Dr Kirsten Kaiser

Executive Vice President Medicinal & Regulatory Development

Dr Kirsten Kaiser was appointed Executive Vice President Medicinal & Regulatory Development on 1 January 2009, having joined the Company as Vice President Clinical Research & Regulatory Affairs in January 2007. Previously, she was Vice President Plasma Integration Office & Medical Operations at ZLB Plasma Services, Vice-President Medical & Safety Operations at Aventis Bio-Services and Vice-President Worldwide Regulatory Affairs at Aventis Behring. Prior to this she held a variety of regulatory affairs and pharmacovigilance roles at Behringwerke AG earlier in her career. Dr Kaiser holds a medical degree from Justus-Liebig University, Giessen in Germany.


Dr Kirsten Kaiser Dr Kirsten Kaiser

> Executive management

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.